Lisa Gill
Stock Analyst at JP Morgan
(3.18)
# 1,143
Out of 4,734 analysts
126
Total ratings
47.62%
Success rate
1.02%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Downgrades: Neutral | $18 | $13.82 | +30.25% | 2 | Dec 17, 2024 | |
| INNV InnovAge Holding | Downgrades: Underweight | $5 | $3.57 | +40.06% | 4 | Dec 17, 2024 | |
| SGRY Surgery Partners | Maintains: Neutral | $38 → $28 | $20.19 | +38.68% | 4 | Dec 3, 2024 | |
| PRVA Privia Health Group | Maintains: Overweight | $27 → $28 | $22.24 | +25.90% | 4 | Nov 29, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Overweight | $20 → $15 | $12.52 | +19.81% | 14 | Aug 30, 2024 | |
| TDOC Teladoc Health | Maintains: Neutral | $16 → $9 | $9.09 | -0.99% | 9 | Aug 26, 2024 | |
| OMI Owens & Minor | Maintains: Underweight | $22 → $18 | $14.58 | +23.46% | 4 | Aug 21, 2024 | |
| MCK McKesson | Maintains: Overweight | $656 → $661 | $592.57 | +11.55% | 13 | Aug 21, 2024 | |
| HUM Humana | Maintains: Neutral | $332 → $396 | $282.63 | +40.11% | 5 | Aug 21, 2024 | |
| CI The Cigna Group | Maintains: Overweight | $435 → $438 | $283.99 | +54.23% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $287 | $242.05 | +18.57% | 1 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $111 → $123 | $126.27 | -2.59% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $21.13 | +37.25% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $14.10 | +27.66% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $286.21 | +38.01% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $238.56 | +1.86% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $101 → $86 | $52.62 | +63.44% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $184.80 | +0.65% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $546 → $559 | $509.76 | +9.66% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $130.86 | +6.98% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $152 → $155 | $151.20 | +2.51% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $310.45 | +6.94% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $385.29 | +63.77% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.57 | +118.82% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $3.09 | +191.26% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.65 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.99 | +0.13% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $46 → $44 | $29.16 | +50.89% | 2 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.22 | +13.36% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $10 | $14.58 | -31.41% | 3 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $62.25 | +57.43% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $24 | $30.90 | -22.33% | 4 | Jun 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.43 | - | 4 | Dec 19, 2017 |
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $13.82
Upside: +30.25%
InnovAge Holding
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.57
Upside: +40.06%
Surgery Partners
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $20.19
Upside: +38.68%
Privia Health Group
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $22.24
Upside: +25.90%
Walgreens Boots Alliance
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $12.52
Upside: +19.81%
Teladoc Health
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $9.09
Upside: -0.99%
Owens & Minor
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $14.58
Upside: +23.46%
McKesson
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $592.57
Upside: +11.55%
Humana
Aug 21, 2024
Maintains: Neutral
Price Target: $332 → $396
Current: $282.63
Upside: +40.11%
The Cigna Group
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $283.99
Upside: +54.23%
Aug 21, 2024
Maintains: Overweight
Price Target: $280 → $287
Current: $242.05
Upside: +18.57%
Aug 21, 2024
Maintains: Neutral
Price Target: $111 → $123
Current: $126.27
Upside: -2.59%
Aug 19, 2024
Initiates: Overweight
Price Target: $29
Current: $21.13
Upside: +37.25%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $14.10
Upside: +27.66%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $286.21
Upside: +38.01%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $238.56
Upside: +1.86%
May 30, 2024
Maintains: Overweight
Price Target: $101 → $86
Current: $52.62
Upside: +63.44%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $184.80
Upside: +0.65%
May 30, 2024
Maintains: Overweight
Price Target: $546 → $559
Current: $509.76
Upside: +9.66%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $130.86
Upside: +6.98%
May 30, 2024
Maintains: Neutral
Price Target: $152 → $155
Current: $151.20
Upside: +2.51%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $310.45
Upside: +6.94%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $385.29
Upside: +63.77%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.57
Upside: +118.82%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $3.09
Upside: +191.26%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.65
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.99
Upside: +0.13%
Oct 18, 2023
Maintains: Overweight
Price Target: $46 → $44
Current: $29.16
Upside: +50.89%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.22
Upside: +13.36%
Jul 7, 2023
Maintains: Neutral
Price Target: $12 → $10
Current: $14.58
Upside: -31.41%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $62.25
Upside: +57.43%
Jun 7, 2018
Maintains: Underweight
Price Target: $26 → $24
Current: $30.90
Upside: -22.33%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $22.43
Upside: -